ÂÜÀòÂÒÂ×

Sophie Brac de la Perrière has a diverse work experience in various industries. Sophie is currently a Board Member at France Biotech, starting in December 2021. Prior to this, they served as the CEO of Healshape, a regenerative medicine project focused on breast regeneration bio-printed solutions for breast cancer survivors. Their tenure at Healshape began in September 2019.

Before Healshape, they worked at FEE Lyon Tech as a Jury member and coach of student entrepreneurs from January 2019 to September 2019.

From 2003 to 2018, Sophie Brac de la Perrière held multiple roles at Sanofi Pasteur, a leading pharmaceutical company. These roles included International Customer Service Director (April 2015 to December 2018), Director of International Business Development for Vaccines (December 2010 to March 2015), Business Development for Vaccines in Asia and the US (September 2009 to November 2010), and Mergers & Acquisitions Project Manager (March 2003 to November 2009). As a Project Manager, they were responsible for assessing new opportunities, conducting financial analysis and valuations, coordinating internal teams, and leading negotiations.

Earlier in their career, they worked as an Analyst in gas purchasing pilot project at Dalkia Utility from January 2002 to July 2002, and as a Junior Manager in Mergers & Acquisitions at Sanofi-Synthelabo from April 2001 to July 2001. During their role at Sanofi-Synthelabo, they were involved in the sale of a pharmaceutical laboratory and conducted comparative studies on acquisitions' rules in China and Japan.

Overall, Sophie Brac de la Perrière has demonstrated expertise in various domains, including regenerative medicine, business development, project management, and mergers & acquisitions.

Sophie Brac de la Perrière attended HEC Paris from 1998 to 2002, where they focused on Finance and Entrepreneurship. In 2001, they briefly studied Corporate Financial and Integrated Risk Management at The University of Manchester.